The US Food and Drug Administration has approved afamitresgene autoleucel (afami-cel) (Tecelra, Adaptimmune LLC) to treat ...

The expanded approval is based on improved survival outcomes observed in the RUBY trial population of patients with advanced ...

Kresse highlighted a 2024 report by the Association of Certified Fraud Examiners, which found that the median fraud loss in ...

A multicomponent nonpharmaceutical intervention improves sleep in people with dementia living at home, early results from a ...

Through a recent document, experts aim to enable researchers and PRPs to establish effective and mutually beneficial ...

Researchers collected data on firearm injuries and deaths from 2019 to 2020 in the United States to determine how many ...

To overcome the obstacles that discourage sex workers from seeking care, some organizations bring care directly to the ...

"What remains unclear is whether abnormal sleep patterns are a cause or an effect of chronic diseases," Baldomero noted.

A study found no significant differences in the risk for PsA among patients with psoriasis treated with interleukin (IL)-23 ...

A high dose of upadacitinib resulted in a meaningful clinical response in a study of several patients with long-standing ...

Emerging predictive tools and novel therapeutic approaches could reduce eye injections for patients with dry and wet ...

Addressing 14 modifiable risk factors over the life course could prevent or delay nearly half of dementia cases worldwide, ...